Factors influencing the initiation of biologic therapy in children with severe asthma: Results of the pediatric asthma noninvasive diagnostic approaches (PANDA) study
Pediatric Pulmonology · 2024
DOI: 10.1002/ppul.27145 ↗At a glance
Journal article in Pediatric Pulmonology, 2024. Written by Yoni E van Dijk and 9 co-authors. Institution: Department of Pediatric Pulmonology and Allergy, Emma Children's Hospital, Amsterdam UMC, Amsterdam, The Netherlands. Major MEDLINE topics: Asthma, Biological Products. Cited 3 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Lung Foundation Netherlands.
Topics: Kinderkrankenpflege
Abstract (original language)
Background & objectives Despite the availability of biologics for severe pediatric asthma, real‐life studies reporting on drivers behind initiating biologics and their alignment with the Global Initiative for Asthma (GINA) recommendations are lacking.
Methods
We performed analysis within the pediatric asthma noninvasive diagnostic approaches study, a prospective cohort of 6‐ to 17‐year‐old children with severe asthma. Information was collected on demographic factors, symptom control, treatment, comorbidities, and diagnostic tests from medical records and questionnaires. We divided patients into “starters” or “nonstarters” based on the clinical decision to initiate biologics and performed multivariate logistic regression analysis to identify drivers behind initiating therapy. Additionally, we assessed patient suitability for biologics according to key factors in the GINA recommendations: Type 2 inflammation, frequency of exacerbations, and optimization of treatment adherence.
Results
In total, 72 children (mean age 11.5 ± 3.0 years, 65.3% male) were included (13 starters). Initiation of biologics was associated with a higher GINA treatment step (adjusted odds ratio's [aOR] = 5.0, 95%CI 1.33–18.76), steroid toxicity (aOR = 21.1, 95%CI 3.73–119.91), frequency of exacerbations (aOR = 1.6, 95%CI 1.10–2.39), improved therapy adherence (aOR = 1.7, 95%CI 1.10–2.46), Caucasian ethnicity (aOR = 0.20, 95%CI 0.05–0.80), ≥1 allergic sensitization (aOR = 0.06, 95%CI 0.004–0.97), and allergic rhinitis (aOR = 0.13, 95%CI 0.03–0.65). Furthermore, steroid toxicity was identified as an important factor for deviation from the current recommendations on biologic prescription.
Conclusions
We identified multiple drivers and inhibitors for initiating biologics, and showed the clinical need for biologics in severe pediatric asthmatics suffering from steroid toxicity. These findings may help refine asthma management guidelines.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pediatric Pulmonology and Allergy, Emma Children's Hospital, Amsterdam UMC, Amsterdam, The Netherlands.
- Department of Pulmonary Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
- Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.
- Amsterdam Public Health, Amsterdam, the Netherlands.
- Department of Pediatric Medicine, Tergooi Medical Center, Hilversum, The Netherlands.
ORCID profiles: Yoni E van Dijk, Simone Hashimoto, Suzanne W J Terheggen-Lagro, Susanne J H Vijverberg
Funding
- Lung Foundation Netherlands
Cite
APA
van Dijk, Y. E., Brandsen, M. A., Hashimoto, S., Rutjes, N. W., Golebski, K., Vermeulen, F., Terheggen-Lagro, S. W. J., van Ewijk, B. E., der Zee, A. M., & Vijverberg, S. J. H. (2024). Factors influencing the initiation of biologic therapy in children with severe asthma: Results of the pediatric asthma noninvasive diagnostic approaches (PANDA) study. Pediatric Pulmonology. https://doi.org/10.1002/ppul.27145
Vancouver
van Dijk YE, Brandsen MA, Hashimoto S, Rutjes NW, Golebski K, Vermeulen F, et al. Factors influencing the initiation of biologic therapy in children with severe asthma: Results of the pediatric asthma noninvasive diagnostic approaches (PANDA) study. Pediatric Pulmonology. 2024. doi:10.1002/ppul.27145
BibTeX
@article{vanDijk2024,
author = {van Dijk, Yoni E and Brandsen, Milou A and Hashimoto, Simone and Rutjes, Niels W and Golebski, Kornel and Vermeulen, Frederique and Terheggen-Lagro, Suzanne W J and van Ewijk, Bart E and der Zee, Anke-Hilse Maitland-van and Vijverberg, Susanne J H},
title = {Factors influencing the initiation of biologic therapy in children with severe asthma: Results of the pediatric asthma noninvasive diagnostic approaches (PANDA) study},
journal = {Pediatric Pulmonology},
year = {2024},
doi = {10.1002/ppul.27145}
}
EUVIMED